SPARK was initially established in 2006 at Stanford to advance new biomedical research discoveries into promising new treatments for patients. SPARK emphasizes new ways of thinking about bridging the gap between bench and bedside. SPARK is a unique partnership between university and industry experts. Currently SPARK global includes more than 18 countries and more than 50 major universities all over the world. Director Jane Tseng from our Drug Research Center is recently appointed to the SPARK Asia Director for this global research effort.
20180807.jpg